Cargando…

Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer

PURPOSE: To analyze the influence of hormone receptors (HR) and Human Epidermal growth factor Receptor-2 (HER2)-based molecular subtypes in stage III inflammatory breast cancer (IBC) on tumor characteristics, treatment, pathologic response to neoadjuvant chemotherapy (NACT), and overall survival (OS...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Uden, Dominique J. P., van Maaren, Marissa C., Bult, Peter, Strobbe, Luc J. A., van der Hoeven, J. J. M., Blanken-Peeters, Charlotte F. J. M., Siesling, Sabine, de Wilt, Johannes H. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548753/ https://www.ncbi.nlm.nih.gov/pubmed/30972613 http://dx.doi.org/10.1007/s10549-019-05219-7

Ejemplares similares

Metastatic behavior and overall survival according to breast cancer subtypes in stage IV inflammatory breast cancer
por: van Uden, D. J. P., et al.
Publicado: (2019)

Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017
por: van der Meer, Daniël J., et al.
Publicado: (2020)

Routine and interval detection of locoregional breast cancer recurrences and risk of subsequent distant metastasis
por: Eijkelboom, Anouk H., et al.
Publicado: (2022)

Conditional local recurrence risk: the effect of event-free years in different subtypes of breast cancer
por: Moossdorff, M., et al.
Publicado: (2021)

Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model
por: Völkel, Vinzenz, et al.
Publicado: (2021)

The effect of breast MRI on disease-free and overall survival in breast cancer patients: a retrospective population-based study
por: van Nijnatten, T. J. A., et al.
Publicado: (2020)

Breast-conserving therapy versus mastectomy
por: van Maaren, Marissa C., et al.
Publicado: (2016)

Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer
por: Dackus, Gwen M. H. E., et al.
Publicado: (2020)

Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple‐negative breast cancer
por: Heeg, Erik, et al.
Publicado: (2019)

Patterns and predictors of first and subsequent recurrence in women with early breast cancer
por: Geurts, Y. M., et al.
Publicado: (2017)

Changes in breast cancer treatment during the COVID-19 pandemic: a Dutch population-based study
por: Eijkelboom, Anouk H., et al.
Publicado: (2022)

Personalisation of breast cancer follow-up: a time-dependent prognostic nomogram for the estimation of annual risk of locoregional recurrence in early breast cancer patients
por: Witteveen, Annemieke, et al.
Publicado: (2015)

The association of socioeconomic status on treatment strategy in patients with stage I and II breast cancer in the Netherlands
por: Filipe, M. D., et al.
Publicado: (2021)

External validation of 87 clinical prediction models supporting clinical decisions for breast cancer patients
por: Hueting, Tom A., et al.
Publicado: (2023)

Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer
por: Kwast, A B G, et al.
Publicado: (2012)

Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival
por: Moncada-Torres, Arturo, et al.
Publicado: (2021)

The increasing importance of histologic grading in tailoring adjuvant systemic therapy in 30,843 breast cancer patients
por: van Dooijeweert, C., et al.
Publicado: (2021)

Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers
por: Lobbes, Marc B.I., et al.
Publicado: (2017)

Socioeconomic status and its relation with breast cancer recurrence and survival in young women in the Netherlands
por: van Maaren, Marissa C., et al.
Publicado: (2022)

Effectiveness of radiotherapy after breast-conserving surgery in older patients with T1-2N0 breast cancer
por: de Boer, Anna Z., et al.
Publicado: (2019)

Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival
por: Vos, Elvira L., et al.
Publicado: (2017)

Inequalities in the omission of axillary dissection in sentinel lymph node positive patients in the Netherlands: Innovative hospitals are early adopters of a de‐escalating approach
por: van Steenhoven, Julia E. C., et al.
Publicado: (2022)

Contralateral breast cancer risk in relation to tumor morphology and age—in which patients is preoperative MRI justified?
por: de Glas, N. A., et al.
Publicado: (2015)

Quantifying the Mitigating Effects of Whole-Breast Radiotherapy and Systemic Treatments on Regional Recurrence Incidence Among Breast Cancer Patients
por: van Steenhoven, Julia E. C., et al.
Publicado: (2020)

Follow‐up after breast cancer: Variations, best practices, and opportunities for improvement according to health care professionals
por: Ankersmid, Jet W., et al.
Publicado: (2021)

Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy
por: Verreck, Eline E. F., et al.
Publicado: (2023)

Trends in incidence, treatment, survival and subsequent breast cancer in lobular carcinoma in situ in the Netherlands: A population-based analysis
por: van Maaren, Marissa C., et al.
Publicado: (2021)

Relations between recurrence risk perceptions and fear of cancer recurrence in breast cancer survivors
por: Ankersmid, J. W., et al.
Publicado: (2022)

The use and misuse of risk prediction tools for clinical decision-making
por: van Maaren, Marissa C., et al.
Publicado: (2023)

Population-based estimates of overtreatment with adjuvant systemic therapy in early breast cancer patients with data from the Netherlands and the USA
por: Ragusi, M. A. A., et al.
Publicado: (2022)

Facilitating validation of prediction models: a comparison of manual and semi-automated validation using registry-based data of breast cancer patients in the Netherlands
por: van Steenbeek, Cornelia D., et al.
Publicado: (2019)

Racial inequities in second-line treatment and overall survival among patients with metastatic breast cancer
por: Whitaker, Kristen D., et al.
Publicado: (2022)

Prognostic models in male breast cancer
por: van der Pol, Carmen C., et al.
Publicado: (2016)

Breast cancer incidence and survival in Scotland by socio-economic deprivation and tumour subtype
por: Mesa-Eguiagaray, Ines, et al.
Publicado: (2022)

The impact of health symptoms on health-related quality of life in early-stage breast cancer survivors
por: de Ligt, K. M., et al.
Publicado: (2019)

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
por: Doebar, Shusma C., et al.
Publicado: (2016)

The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival
por: van Maaren, Marissa C, et al.
Publicado: (2017)

Improved survival of older patients with advanced breast cancer due to an increase in systemic treatments: a population-based study
por: de Glas, Nienke, et al.
Publicado: (2019)

The risk of cardiovascular disease following breast cancer by Framingham risk score
por: Gernaat, Sofie A. M., et al.
Publicado: (2018)

Age of mother and grandmother in relation to a subject's breast cancer risk
por: de Haan, M C, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_t9l2bo0j3v9r07vhhoipaf63k5